Atazanavir C₃₈H₅₂N₆O₇
Active ingredient description
Atazanavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag-Pol proteins in HIV-1 infected cells, thus preventing formation of mature virions and infection of other cells.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Chemical formula: C₃₈H₅₂N₆O₇
Molecular mass: 704.856 g/mol
External identifiers
Medicines
Atazanavir is an active ingredient of these brands:
Brazil (BR)
- REYATAZ as ATAZANAVIR SULFATE
Canada (CA)
- REYATAZ as ATAZANAVIR SULFATE
Cyprus (CY)
- REYATAZ as ATAZANAVIR SULFATE
Finland (FI)
- (combination) EVOTAZ as ATAZANAVIR SULFATE
France (FR)
- REYATAZ as ATAZANAVIR SULFATE
Hong Kong (HK)
- REYATAZ as ATAZANAVIR SULFATE
Japan (JP)
- REYATAZ as ATAZANAVIR SULFATE
Netherlands (NL)
- REYATAZ as ATAZANAVIR SULFATE
New Zealand (NZ)
- REYATAZ as ATAZANAVIR SULFATE
Singapore (SG)
- REYATAZ as ATAZANAVIR SULFATE
South Africa (ZA)
While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.